CLINICAL_TRIALS
trial_result
· 2013-02-04
Clinical Trial Update: Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia
Summary
Completed clinical trial examining tricuspid regurgitant jet velocity as an independent predictor of mortality in sickle cell disease with pulmonary hypertensio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Namita Sood | Conditions: Sickle Cell Anemia, Pulmonary Hypertension | Status: COMPLETED